Clinical decisions. Management of type 2 diabetes--polling results.
Halperin
Florencia
F
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Ingelfinger
Julie R
JR
McMahon
Graham T
GT
D001835:Body Weight / Q000187:drug effects; D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D000077270:Exenatide; D005913:Glipizide / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000191:economics; D007336:Insulin, Isophane / Q000008:administration & dosage*; D008687:Metformin / Q000627:therapeutic use; D010455:Peptides / Q000008:administration & dosage; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage; D014688:Venoms / Q000008:administration & dosage
D000077270:Exenatide; D005913:Glipizide; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007336:Insulin, Isophane; D008687:Metformin; D010455:Peptides; D000077205:Pioglitazone; D045162:Thiazolidinediones; D014688:Venoms